Lipophilic quenching of viral inactivating agents
AssigneeV. I. Technologies, Inc.
InventorsClark M. Edson, Andrei A. Purmal, Samuel K. Ackerman
Life of this patent
Estimating the term…
Loading patent…
AssigneeV. I. Technologies, Inc.
InventorsClark M. Edson, Andrei A. Purmal, Samuel K. Ackerman
Estimating the term…
Methods and compositions for the inactivation and removal of contaminants of a biological composition are disclosed. The methods include the steps of: (a) contacting the biological composition with an inactivating agent including an aziridino moiety, such as ethyleneimine, an oligomer of ethyleneimine, or a haloderivative salt of either ethyleneimine or an oligomer of ethyleneimine, where a portion of the agent reacts with and inactivates the contaminant, and a portion of the agent remains unreacted; (b) contacting the product of step (a) with a lipophilic quenching agent including at least one quenching moiety attached to a lipophilic moiety, under conditions and for a time sufficient to allow the unreacted agent to bond covalently to the quenching moiety; and (c) separating the lipophilic quenching agent and the quenched inactivating agent from the biological composition.
A method of inactivating a nucleic acid-containing contaminant of an isolated biological composition, said method comprising the steps of:
A method of removing an electrophilic viral inactivating agent containing an aziridino moiety or a haloderivative thereof from an isolated biological composition, said method comprising the steps of:
Dependencies are inferred from the claim text.